NCT06060314

Comparison of Efficacy Between Conservative Versus Operative Management of Carpel Tunnel Syndrome

Completed NA Last updated 29 September 2023

What this trial tests

NA trial testing Conservative Approach in Carpal Tunnel Syndrome in 60 participants. Completed in 3 September 2022.

Timeline

3 March 2022

Primary endpoint
3 June 2022

3 September 2022

Quick facts

Lead sponsor	Combined Military Hospital Abbottabad
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	60
Start date	3 March 2022
Primary completion	3 June 2022
Estimated completion	3 September 2022
Sites	1 location across Pakistan

Drugs / interventions tested

• Conservative Approach
• Surgical Approach

Conditions studied

• Carpal Tunnel Syndrome — all drugs for Carpal Tunnel Syndrome →

Sponsor

Combined Military Hospital Abbottabad

Who can join

Adults 18 to 60, any sex, with Carpal Tunnel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients presented with symptoms of numbness at night, pain, or tingling sensation in the fingers particularly at night diagnosed by consultant orthopedic surgeon on physical examination. Patients in Group A were treated conservatively i.e splinting in neutral position of wrist for 6 wks min at night and during the day as preferred while patients in Group B were managed through surgical intervention i.e open carpal tunnel release (OCTR). Patients were assessed during a follow up visit at 3rd month measured using functional status scale of the Boston questionnaire (BQ). Efficacy was determined in terms of functional improvement from the baseline.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.